Pulmonary Vein Isolation Using a Second-Generation Cryoballoon in Patients With Paroxysmal Atrial Fibrillation: One-Year Outcome Using a Single Big-Balloon 3-Minute Freeze Technique

Journal of Cardiovascular Electrophysiology

Volumn 27, Issue 12, 2016, Pages 1375-1380

  Miyazaki, Shinsuke ^a   Hachiya, Hitoshi ^a   Nakamura, Hiroaki ^a   Taniguchi, Hiroshi ^a   Takagi, Takamitsu ^a   Hirao, Kenzo ^b   Iesaka, Yoshito ^a  

^a TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

atrial fibrillation; catheter ablation; cryoballoon; phrenic nerve paralysis; pulmonary vein isolation

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; BALLOON CATHETER; CATHETER ABLATION; CLINICAL ASSESSMENT; CLINICAL OUTCOME; CONTROLLED STUDY; CRYOABLATION; CRYOBALLOON ABLATION; CRYOTHERAPY; DISEASE ASSOCIATION; EARLY ATRIAL FIBRILLATION; FEMALE; FLUOROSCOPY; FREEZE THAWING; HEART TAMPONADE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; NERVE INJURY; PAROXYSMAL ATRIAL FIBRILLATION; PATIENT MONITORING; PHRENIC NERVE; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; PULMONARY VEIN STENOSIS; RECURRENT DISEASE; REPEAT PROCEDURE; AGED; ATRIAL FIBRILLATION; CRYOSURGERY; DEVICES; DISEASE FREE SURVIVAL; EQUIPMENT DESIGN; FEASIBILITY STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PULMONARY VEIN; REOPERATION; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CRYOSURGERY; DISEASE-FREE SURVIVAL; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PULMONARY VEINS; RECURRENCE; REOPERATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84992650909     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.13078     Document Type: Article

References (24)

1. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
2. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D: 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2012;9:632-696.
3. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN; STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: First results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 2013;61:1713-1723.
4. Coulombe N, Paulin J, Su W: Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol 2013;24:919-925.
5. Miyazaki S, Hachiya H, Taniguchi H, Nakamura H, Ichihara N, Usui E, Kuroi A, Takagi T, Iwasawa J, Hirao K, Iesaka Y: Prospective evaluation of bilateral diaphragmatic electromyograms during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2015;26:622-628
6. Su W, Kowal R, Kowalski M, Metzner A, Svinarich JT, Wheelan K, Wang P: Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3000 procedures. Heart Rhythm 2015;12:1658-1666.
7. Takagi T, Miyazaki S, Kusa S, Taniguchi H, Ichihara N, Iwasawa J, Kuroi A, Nakamura H, Hachiya H, Hirao K, Iesaka Y: Role of extended external auto-triggered loop recorder monitoring for atrial fibrillation. Circ J 2014;78:2637-2642.
8. Avitall B, Kalinski A: Cryotherapy of cardiac arrhythmia: From basic science to the bedside. Heart Rhythm 2015;12:2195-2203.
9. Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, Sirois MG, Santoianni D, Dubuc M: Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003;107:2045-2050.
10. Martins RP, Hamon D, Césari O, Behaghel A, Behar N, Sellal JM, Daubert JC, Mabo P, Pavin D: Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm 2014;11:386-393.
11. Straube F, Dorwarth U, Schmidt M, Wankerl M, Ebersberger U, Hoffmann E: Comparison of the first and second cryoballoon: High-volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol 2014;7:293-299.
12. Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Hunuk B, Chierchia GB, Brugada P: Single 3-minute freeze for second-generation cryoballoon ablation: One-year follow-up after pulmonary vein isolation. Heart Rhythm 2014;12:673-680.
13. Takami M, Lehmann HI, Misiri J, Parker KD, Sarmiento RI, Johnson SB, Packer DL: The impact of freezing time and balloon size on the thermodynamics and isolation efficacy during pulmonary vein isolation using the 2nd generation cryoballoon. Circ Arrhythm Electrophysiol 2015;8:836-845.
14. Aryana A, Singh SM, Kowalski M, Pujara DK, Cohen AI, Singh SK, Aleong RG, Banker RS, Fuenzalida CE, Prager NA, Bowers MR, D'Avila A, O'Neill PG: Acute and long-term outcomes of catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: A multicenter experience. J Cardiovasc Electrophysiol 2015;26:832-839.
15. Cardoso R, Mendirichaga R, Fernandes G, Healy C, Lambrakos LK, Viles-Gonzalez JF, Goldberger JJ, Mitrani RD: Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation: A meta-analysis. J Cardiovasc Electrophysiol 2016;27:1151-1159.
16. Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C; FIRE and ICE Investigators: Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 2016;374:2235-2245.
17. Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck K, Kuniss M, Willems S, Deneke T, Tebbenjohanns J, Gerds-Li JH, Spitzer S, Senges J, Hochadel M, Hoffmann E: German ablation registry: Cryoballoon vs radiofrequency ablation in paroxysmal atrial fibrillation-one-year outcome data. Heart Rhythm 2016;13:836-844.
18. Heeger CH, Wissner E, Mathew S, Deiss S, Lemes C, Rillig A, Wohlmuth P, Reissmann B, Tilz RR, Ouyang F, Kuck KH, Metzner A: Once isolated, always isolated? Incidence and characteristics of pulmonary vein reconduction after second-generation cryoballoon-based pulmonary vein isolation. Circ Arrhythm Electrophysiol 2015;8:1088-1094.
19. Reddy VY, Sediva L, Petru J, Skoda J, Chovanec M, Chitovova Z, Di Stefano P, Rubin E, Dukkipati S, Neuzil P: Durability of pulmonary vein isolation with cryoballoon ablation: Results from the sustained PV isolation with arctic front advance (SUPIR) study. J Cardiovasc Electrophysiol 2015;26:493-500.
20. Ciconte G, Sieira-Moret J, Hacioglu E, Mugnai G, DI Giovanni G, Velagic V, Saitoh Y, Conte G, Irfan G, Baltogiannis G, Hunuk B, Stroker E, Brugada P, DE Asmundis C, Chierchia GB: Single 3-minute versus double 4-minute freeze strategy for second-generation cryoballoon ablation: A single-center experience. J Cardiovasc Electrophysiol 2016;27:796-803.
21. Miyazaki S, Taniguchi H, Nakamura H, Takagi T, Iwasawa J, Hachiya H, Iesaka Y: Clinical significance of early recurrence after pulmonary vein antrum isolation in paroxysmal atrial fibrillation—Insight into the mechanism. Circ J 2015;79:2353-2359.
22. Miyazaki S, Kuroi A, Hachiya H, Nakamura H, Taniguchi H, Ichihara N, Takagi T, Iwasawa J, Iesaka Y: Early recurrence after pulmonary vein isolation of paroxysmal atrial fibrillation with different ablation technologies—Prospective comparison of radiofrequency vs. second-generation cryoballoon ablation. Circ J 2016;80:346-353.
23. Joshi S, Choi AD, Kamath GS, Raiszadeh F, Marrero D, Badheka A, Mittal S, Steinberg JS: Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: Findings from 3 months of continuous automatic ECG loop recordings. J Cardiovasc Electrophysiol 2009;20:1089–1094.
24. Andrade JG, Khairy P, Macle L, Packer DL, Lehmann JW, Holcomb RG, Ruskin JN, Dubuc M: Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: Insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol 2014;7:69-75.